BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Niu MY, Dong GT, Li Y, Luo Q, Cao L, Wang XM, Wang QW, Wang YT, Zhang Z, Zhong XW, Dai WB, Li LY. Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway. World J Gastroenterol 2024; 30(30): 3584-3608 [PMID: 39193572 DOI: 10.3748/wjg.v30.i30.3584]
URL: https://www.wjgnet.com/1007-9327/full/v30/i30/3584.htm
Number Citing Articles
1
Sabrina Alves Fernandes, Claudio A Marroni, Norma P Marroni, Carina Rossoni, Maria Luiza Fernandes Dahlem, Santiago Rodriguez. Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver diseaseWorld Journal of Hepatology 2025; 17(8): 108182 doi: 10.4254/wjh.v17.i8.108182
2
Bassam S. M. Al Kazman, Sadia Rana, Faiza Naseer, Taha Muhammad, Ethar Abdullah Mudhish, Mohammed A. Alshamrani, Omaish S. Alqahtani, Mater H. Mahnashi, Mohammad Saleem. Therapeutic Potential of Conyza bonariensis n‐Hexane Extract in Non‐Alcoholic Fatty Liver Disease: Histological, Biochemical, and In Silico Insights From a High‐Fat Diet Rat ModelFood Science & Nutrition 2025; 13(9) doi: 10.1002/fsn3.70950
3
Wenting Zhu, Xiao Liu, Yuhan Jiang, Ye Cao, Gaojing Yang, Huizhen Chen, Qiaoqiao Chen, Qiao Wang, Zibo Dong. Atraric acid alleviates spleen tissue damage caused by high-fat diet model by phosphorylating ULK1Archives of Biochemistry and Biophysics 2026; 783 doi: 10.1016/j.abb.2026.110883
4
P.B. Apoorva, B. Sajeev Kumar, P. Sathishbabu. Next-generation lipid nanoplatforms for phytoconstituent delivery in MASLD managementJournal of Drug Delivery Science and Technology 2026; 124 doi: 10.1016/j.jddst.2026.108615
5
Bhupesh Singla. Fanlian Huazhuo Formula: A promising herbal preparation for metabolic liver diseaseWorld Journal of Gastroenterology 2024; 30(46): 4964-4968 doi: 10.3748/wjg.v30.i46.4964
6
Hassan Barakat, Hani A. Alfheeaid. Probiotic Modulation of Gut Microbiota: Antioxidant Mechanisms and Clinical Benefits in Obesity and Type 2 Diabetes ManagementAntioxidants 2026; 15(6) doi: 10.3390/antiox15060727
7
Lu Jiang, Jian-Gao Fan. Gut microbiota in gastrointestinal diseases: Insights and therapeutic strategiesWorld Journal of Gastroenterology 2024; 30(39): 4329-4332 doi: 10.3748/wjg.v30.i39.4329
8
Tzu-Hurng Cheng, Wen-Rui Hao, Chun-Han Cheng. Fanlian Huazhuo formula: A promising therapeutic approach for metabolic associated steatotic liver diseaseWorld Journal of Gastroenterology 2025; 31(1): 100250 doi: 10.3748/wjg.v31.i1.100250
9
Sampat Singh Tanwar, Seema Sharma. Modulatory Role of Traditional Chinese Medicine in Gut–Liver and Adipose–Liver Axis Dysfunction in MASLDPharmacological Research - Modern Chinese Medicine 2026; 18 doi: 10.1016/j.prmcm.2025.100743
10
Jing-Qing Hu, Hong-Xuan Tong, Yang Ye, Wen-Yi Nie. Herbal medicine as a potential treatment for non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2025; 31(9): 100273 doi: 10.3748/wjg.v31.i9.100273
11
Wen-Yige Zhang, Meng-Hui Wang, Chuan Xie. Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising futureWorld Journal of Gastroenterology 2024; 30(43): 4597-4601 doi: 10.3748/wjg.v30.i43.4597